PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Igniting hope for people living with chronic kidney disease

“Back to the Wall — Ignite Hope of Life” was officially launched at the 16th Asian Pacific Congress of Nephrology (APCN) in Beijing.
 

David Grier, Harry de Wit (CEO, Fresenius Medical Care (FME) Asia Pacific), Andrew Stuart

Fresenius Medical Care, the world’s largest provider of dialysis products and services, has announced a new partnership with extreme adventurer, David Grier, who will attempt to run the 4000km route of the Great Wall of China in just 70 days, raising awareness of kidney health and chronic kidney disease.

“Back to the Wall — Ignite Hope of Life” was officially launched at the 16th Asian Pacific Congress of Nephrology (APCN) in Beijing. The corporate social responsibility (CSR) campaign’s name celebrates David Grier’s return to the Great Wall. Twelve years after becoming one of the first people in history to run the entire route of the Great Wall of China, 58-year old David and his running partner Andrew Stuart (50) will now complete the run in the other direction. In 2006, he ran the route in 98 days, and now plans to shave 28 days off his time. The campaign’s name also acknowledges the importance of hope in all our lives, and especially the hope for people with chronic kidney disease (CKD) to lead fuller, more active and vibrant lives.
Professor Yu Xueqing, Professor of Medicine and Director of Sun Yat-sen University’s Institute of Nephrology , Vice President of The First Affiliated Hospital, and President of the Chinese Society of Nephrology (CSN),  welcomed news of the kidney health initiative: “There are 130 million people living with CKD in China. To help tackle the problem, the Chinese Government has announced a series of healthcare policies to build health insurance programs and a medical referral  system for critical illness. The Fresenius Medical Care campaign will complement these government initiatives while playing a vital role in promoting kidney care knowledge and raising awareness for chronic kidney disease.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026